These results suggest that ER phosphorylation alters receptor function (promoter targeting, chromatin remodeling and transcriptional output) effecting changes that could lead to a more sensitive response to EGF stimuli, as reported for tamoxifen-resistant breast tumors [43], [44]. This evidence concerns the gene EGF and breast neoplasm.